Growth Metrics

Wave Life Sciences (WVE) Operating Income Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 12.69%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 75.16%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -347.04%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 80.62%
7 Evaxion A 64.16 Bn 64.14 Bn - 1.27%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 8.65%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,386.07%
10 Wave Life Sciences 1.32 Bn 772.50 Mn - 37.16%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 37.16%
Dec 31, 2025 -345.86%
Sep 30, 2025 11.83%
Jun 30, 2025 -50.75%
Mar 31, 2025 -44.54%
Dec 31, 2024 222.94%
Sep 30, 2024 -1,538.23%
Jun 30, 2024 -49.09%
Mar 31, 2024 -13.78%
Dec 31, 2023 57.11%
Sep 30, 2023 111.42%
Jun 30, 2023 44.33%
Mar 31, 2023 20.50%
Dec 31, 2022 -20.64%
Sep 30, 2022 -411.36%
Jun 30, 2022 -5.87%
Mar 31, 2022 12.37%
Dec 31, 2021 -19.12%
Sep 30, 2021 77.90%
Jun 30, 2021 -3.03%
Mar 31, 2021 13.05%
Dec 31, 2020 49.92%
Sep 30, 2020 36.48%
Jun 30, 2020 15.26%
Mar 31, 2020 -4.18%
Dec 31, 2019 -23.68%
Sep 30, 2019 -41.71%
Jun 30, 2019 -24.73%
Mar 31, 2019 -34.14%
Dec 31, 2018 -57.08%
Sep 30, 2018 -45.08%
Jun 30, 2018 -48.23%
Mar 31, 2018 -77.04%
Dec 31, 2017 -68.39%
Sep 30, 2017 -52.92%
Jun 30, 2017 -112.00%
Mar 31, 2017 -154.11%
Dec 31, 2016 -156.50%
Sep 30, 2016 -245.35%
Jun 30, 2016 -220.69%
Mar 31, 2016 -129.49%
Dec 31, 2015 -305.28%
Sep 30, 2015 -268.54%